Median Technologies (XPAR:ALMDT) FCF Margin % : -81.21% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Median Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Median Technologies's Free Cash Flow for the six months ended in Dec. 2023 was €-8.85 Mil. Median Technologies's Revenue for the six months ended in Dec. 2023 was €10.90 Mil. Therefore, Median Technologies's FCF Margin % for the quarter that ended in Dec. 2023 was -81.21%.

As of today, Median Technologies's current FCF Yield % is -31.68%.

The historical rank and industry rank for Median Technologies's FCF Margin % or its related term are showing as below:

XPAR:ALMDT' s FCF Margin % Range Over the Past 10 Years
Min: -250.76 Med: -100.91 Max: -43.17
Current: -96.87

During the past 13 years, the highest FCF Margin % of Median Technologies was -43.17%. The lowest was -250.76%. And the median was -100.91%.

XPAR:ALMDT's FCF Margin % is ranked worse than
76.56% of 832 companies
in the Medical Devices & Instruments industry
Industry Median: -7.38 vs XPAR:ALMDT: -96.87

Median Technologies FCF Margin % Historical Data

The historical data trend for Median Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Technologies FCF Margin % Chart

Median Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-50.97

-43.17

-51.63

-72.58

-96.87

Median Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-37.60	-84.42	-58.82	-111.94	-81.21

Competitive Comparison of Median Technologies's FCF Margin %

For the Medical Devices subindustry, Median Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Median Technologies's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Median Technologies's FCF Margin % falls into.

Median Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Median Technologies's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-21.53	/	22.226
	=	-96.87 %

Median Technologies's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-8.851	/	10.899
	=	-81.21 %

Median Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Median Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Technologies (XPAR:ALMDT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

4ZG:Germany

Address

1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560

Website

https://www.mediantechnologies.com

Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies (XPAR:ALMDT) Headlines

No Headlines